Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Marijuana for Cancer Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00046709
Recruitment Status : Terminated (Discontinued due to non-enrollment.)
First Posted : October 2, 2002
Last Update Posted : October 10, 2013
University of California, San Francisco
Information provided by:
Center for Medicinal Cannabis Research

Brief Summary:
To find out if it is safe and effective to use smoked marijuana in combination with opioids to treat cancer pain. The study will evaluate whether smoked marijuana, when used with opioids, will have an effect on pain relief, and to see if marijuana reduces the side effects of opioids, which include nausea and/or vomiting.

Condition or disease Intervention/treatment Phase
Neoplasms Drug: Smoked Marijuana Phase 1 Phase 2

Detailed Description:
To take part in this study, you must have ongoing cancer pain which is currently being treated with opioids. If you meet all the eligibility criteria you will be admitted to the General Clinical Research Center at San Francisco General Hospital for 9 days. The treatment consists of smoking one marijuana cigarette 3 times a day.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 16 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Marijuana in Combination With Opioids for Cancer Pain: A Pilot Study
Study Start Date : September 2002
Actual Study Completion Date : October 2004

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Marijuana

Primary Outcome Measures :
  1. Change in level of cancer pain as recorded on a 100mm Visual Analog Scale.

Secondary Outcome Measures :
  1. Change in level of experimentally induced pain on a 100mm Visual Analog Scale.
  2. Change in nausea and emesis in participants exhibiting these symptoms.
  3. Change in disposition kinetics of opioid analgesics.

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No


  • Have ongoing cancer pain
  • Be diagnosed with cancer and have at least a six month survival.
  • Be on a stable dose of opioid medication for at least 2 weeks before enrollment.
  • Have smoked marijuana on at least 6 occasions in their lifetime prior to enrollment.


You must not:

  • Start chemotherapy, radiation or biphosphonates during the study, or have received any new intervention with any such agents within the past 4 weeks.
  • Currently be using smoked tobacco products.
  • Currently be in methadone treatment.
  • Have smoked marijuana within 30 days of enrollment.
  • Be diagnosed with diabetes mellitus.
  • Have severe heart disease, uncontrolled hypertension, or lung disease.
  • Currently be receiving treatment with corticosteroids.
  • Be pregnant or breastfeeding.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00046709

Layout table for location information
United States, California
University of California, San Francisco
San Francisco, California, United States, 94110
Sponsors and Collaborators
Center for Medicinal Cannabis Research
University of California, San Francisco
Layout table for investigator information
Principal Investigator: Donald I Abrams, M.D. UCSF Community Consortium
Additional Information:
Layout table for additonal information Identifier: NCT00046709    
Obsolete Identifiers: NCT00052871
Other Study ID Numbers: C00-SF-108
First Posted: October 2, 2002    Key Record Dates
Last Update Posted: October 10, 2013
Last Verified: October 2013
Keywords provided by Center for Medicinal Cannabis Research:
Cancer pain
All types of cancer except lung cancer
Additional relevant MeSH terms:
Layout table for MeSH terms
Cancer Pain
Neurologic Manifestations